Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperazine, piperidine and tetrahydropyridine derivatives as 5-HT receptor agonists

Piperazine, piperidine and tetrahydropyridine derivatives as 5-HT receptor agonists

US Patent 5998416 · Granted Dec 7, 1999

Estimated economic value: $69,168,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfonamide carboxamide compounds2025
Sulfonamideurea compounds2025
Sulfonamide carboxamide compounds2024
Sulfonamide carboxamide compounds2024
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors2024
Compounds2024
Sulfonylureas and related compounds and use of same2024
Compounds and uses2023
Sulfonamide carboxamide compounds2023
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors2023
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors2023
Sulfonamide carboxamide compounds2022